Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. is a Shanxi-based biotechnology company focused on functional protein materials, including recombinant humanized type III collagen and anti-HPV protein applications. The company maintains joint research platforms with major Chinese universities and has expanded into AI-enabled biomedical and medical aesthetics applications.
Zhang Xingdong serves as Chief Scientific Advisor on biomaterials for Jinbo. He is a prominent biomaterials expert associated with national-level biomedical engineering platforms and has participated in industry forums alongside PLA medical representatives and Jinbo leadership.
The People's Liberation Army Joint Logistic Support Force (JLSF) was established in 2016 under reforms directed by Xi Jinping as Chairman of the Central Military Commission. It oversees unified logistics support across the PLA, including transportation, supply, and medical systems. Military medical institutions, including major PLA hospital centers, operate within this integrated support structure.
Jiang Shibo, Director of the Institute of Medical Microbiology at Fudan University, serves as Chief Scientist for Jinbo. Public records show that he has co-applied for patents and co-authored research with institutes under the Academy of Military Medical Sciences and with the PLA Center for Disease Control and Prevention.
The Academy of Military Medical Sciences (AMMS) is a PLA-affiliated biomedical research body historically responsible for military medical research, including microbiology, epidemiology, and bioengineering. Institutes under AMMS have appeared in joint patent filings and academic publications involving Jiang Shibo and associated research entities.
For a detailed analysis of how these institutional links intersect across corporate, academic, and PLA structures, please read the full article here:#Democracy #Christ #Peace #Freedom #Liberty #Humanrights #人权 #法治 #宪政 #独立审计 #司法独立 #联邦制 #独立自治
No comments:
Post a Comment